Postrock Partners LLC Exact Sciences Corp Transaction History
Postrock Partners LLC
- $206 Billion
- Q4 2024
A detailed history of Postrock Partners LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Postrock Partners LLC holds 12,309 shares of EXAS stock, worth $644,745. This represents 0.34% of its overall portfolio holdings.
Number of Shares
12,309Holding current value
$644,745% of portfolio
0.34%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
666Shares Held
161MCall Options Held
2.3MPut Options Held
2.11M-
Vanguard Group Inc Valley Forge, PA17.8MShares$930 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$830 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$751 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$632 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$350 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.27B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...